返回ChemicalBook首页>CAS数据库列表>1395051-72-5

1395051-72-5

中文名称 化合物 BPR1J-340
英文名称 BPR1J-340
CAS 1395051-72-5
分子式 C29H34N8O3
分子量 542.63
MOL 文件 1395051-72-5.mol
1395051-72-5 结构式 1395051-72-5 结构式

基本信息

中文别名
化合物 BPR1J-340
英文别名
BPR1J-340
N-(3-(4-[([(5-ethyl-3-isoxazolyl)amino]carbonylamino)methyl]phenyl)-1H-5-pyrazolyl)-4-[(4-methylpiperazino)methyl]benzamide

物理化学性质

沸点716.2±60.0 °C(Predicted)
密度1.310±0.06 g/cm3(Predicted)
酸度系数(pKa)12.62±0.70(Predicted)

应用领域

用途一
BPR1J-340 is a potent and selective FLT3 inhibitor with potential anticancer activity. BPR1J-340 was identified as a novel potent FLT3 inhibitor by biochemical kinase activity (IC50 approximately 25 nM) and cellular proliferation (GC50 approximately 5 nM) assays. BPR1J-340 inhibited the phosphorylation of FLT3 and STAT5 and triggered apoptosis in FLT3-ITD(+) AML cells. The pharmacokinetic parameters of BPR1J-340 in rats were determined. BPR1J-340 also demonstrated pronounced tumor growth inhibition and regression in FLT3-ITD(+) AML murine xenograft models. The combination treatment of the HDAC inhibitor vorinostat (SAHA) with BPR1J-340 synergistically induced apoptosis via Mcl-1 down-regulation in MOLM-13 AML cells, indicating that the combination of selective FLT3 kinase inhibitors and HDAC inhibitors could exhibit clinical benefit in AML therapy.

常见问题列表

概述
BPR1J-340 是一种强效的 FLT3 抑制剂,IC50 约为 25 nM。BPR1J-340 可抑制 FLT3 和 STAT5 的磷酸化,并引发 FLT3-ITD+ 急性髓系白血病 (AML) 细胞凋亡 (apoptosis)。BPR1J-340 表现出显著的抗肿瘤活性。
"1395051-72-5" 相关产品信息